Lairson DR - Search Results

1

Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areas.

Fu S, Wang M, Li R, Lairson DR, Zhao B, Du XL. Fu S, et al. Among authors: lairson dr. Cancer Epidemiol. 2019 Feb;58:89-97. doi: 10.1016/j.canep.2018.12.002. Epub 2018 Dec 6. Cancer Epidemiol. 2019. PMID: 30528835 Free PMC article.

2

Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.

Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Gruschkus SK, et al. Cancer. 2010 Nov 15;116(22):5279-89. doi: 10.1002/cncr.25525. Cancer. 2010. PMID: 20665502 Free PMC article.

3

Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.

Panchal JM, Lairson DR, Chan W, Du XL. Panchal JM, et al. Among authors: lairson dr. Clin Colorectal Cancer. 2013 Jun;12(2):113-21. doi: 10.1016/j.clcc.2012.09.007. Epub 2012 Nov 6. Clin Colorectal Cancer. 2013. PMID: 23137529

4

Impact of Hematopoietic Growth Factors on Blood Transfusion Needs, Incidence of Neutropenia, and Overall Survival Among Elderly Advanced Ovarian Cancer Patients Treated With Chemotherapy.

Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Poonawalla IB, et al. Among authors: lairson dr. Int J Gynecol Cancer. 2016 Jan;26(1):95-103. doi: 10.1097/IGC.0000000000000564. Int J Gynecol Cancer. 2016. PMID: 26509851

5

Cost-Effectiveness of Novel Agents in Medicare Patients with Multiple Myeloma: Findings from a U.S. Payer's Perspective.

Chen Y, Lairson DR, Chan W, Huo J, Du XL. Chen Y, et al. Among authors: lairson dr. J Manag Care Spec Pharm. 2017 Aug;23(8):831-843. doi: 10.18553/jmcp.2017.23.8.831. J Manag Care Spec Pharm. 2017. PMID: 28737990 Free PMC article.

6

Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.

Chen Y, Lairson DR, Chan W, Du XL. Chen Y, et al. Among authors: lairson dr. Med Oncol. 2017 Sep;34(9):153. doi: 10.1007/s12032-017-1001-7. Epub 2017 Aug 3. Med Oncol. 2017. PMID: 28776319

7

Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma.

Chen Y, Lairson DR, Chan W, Du XL. Chen Y, et al. Among authors: lairson dr. Ann Hematol. 2018 May;97(5):851-863. doi: 10.1007/s00277-018-3238-4. Epub 2018 Jan 15. Ann Hematol. 2018. PMID: 29333596

8

Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas.

Fu S, Wang M, Lairson DR, Li R, Zhao B, Du XL. Fu S, et al. Among authors: lairson dr. Oncotarget. 2017 Nov 3;8(68):112516-112529. doi: 10.18632/oncotarget.22367. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348844 Free PMC article.

9

Cost Effectiveness of Transplant, Conventional Chemotherapy, and Novel Agents in Multiple Myeloma: A Systematic Review.

Fu S, Wu CF, Wang M, Lairson DR. Fu S, et al. Among authors: lairson dr. Pharmacoeconomics. 2019 Dec;37(12):1421-1449. doi: 10.1007/s40273-019-00828-y. Pharmacoeconomics. 2019. PMID: 31392666

10

Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma.

Fu S, Wang M, Zhao H, Li R, Lairson DR, Giordano SH, Zhao B, Du XL. Fu S, et al. Among authors: lairson dr. Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):e616-e623. doi: 10.1016/j.clml.2019.08.014. Epub 2019 Aug 30. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31563564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters